Merck & Co., Inc. insider buying and selling
5 Form 4 filings against Merck & Co., Inc. (MRK) in the last 90 days. Below are the transactions from 4 recent filings, one per insider where the window allows, as filed.
| Date | Insider and role | Transaction | Code | Shares | Price | Owned after |
|---|---|---|---|---|---|---|
| 2026-11-12 | DeLuca Richard R.EVP&Pres, Merck Animal Heallth | option exercise | M | 58,185 | $77.62 | 171,140 |
| 2026-11-12 | DeLuca Richard R.EVP&Pres, Merck Animal Heallth | open-market sale | S | 58,185 | $148.01 | 112,955 |
What the filings show
Across the 4 filings read here, 1 insider at Merck & Co., Inc. (MRK) filed; that insider reported 1 open-market sale of 58,185 shares worth about $8.6M.
The largest by value was DeLuca Richard R. (EVP&Pres, Merck Animal Heallth), with about $8.6M sold on the open market.
5 Form 4 filings were made against Merck & Co., Inc. in the 90 days to November 20, 2026; the paid report reads all of them.
The Form 4 flow against Merck & Co., Inc., parsed and explained
The free view above is the newest few filings. The paid report reads the newest Form 4 filings of the last 90 days (up to 100), separates open-market buys and sales from awards, exercises and tax withholding, totals the flow per insider, flags 10b5-1 plans where the filing notes them, and hands you a cited write-up plus a downloadable transactions table.
Generated from public SEC EDGAR filings. Filing data is shown as filed. This is information, not investment advice.